Education
About Us
Working with TipRanks
Follow Us
Scope Fluidics SA (DE:S84)
FRANKFURT:S84
S84 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€29.10 - €44.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€107.51M
Enterprise ValueN/A
Total Cash (Recent Filing)€138.13M
Total Debt (Recent Filing)€2.35M
Price to Earnings (P/E)6.7
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.57
Shares Outstanding2,725,930
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
S84 FAQ
What was Scope Fluidics SA’s price range in the past 12 months?
Scope Fluidics SA lowest stock price was €29.10 and its highest was €44.00 in the past 12 months.
What is Scope Fluidics SA’s market cap?
Scope Fluidics SA’s market cap is €107.51M.
When is Scope Fluidics SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scope Fluidics SA’s earnings last quarter?
Currently, no data Available
Is Scope Fluidics SA overvalued?
According to Wall Street analysts Scope Fluidics SA’s price is currently Overvalued.
Does Scope Fluidics SA pay dividends?
Scope Fluidics SA does not currently pay dividends.
What is Scope Fluidics SA’s EPS estimate?
Scope Fluidics SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scope Fluidics SA have?
Scope Fluidics SA has 2,725,930 shares outstanding.
What happened to Scope Fluidics SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scope Fluidics SA?
Currently, no hedge funds are holding shares in DE:S84
Company Description
Scope Fluidics SA
Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare. It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.
Technical Analysis
Biomaxima SA
―
Genomtec SA
―
Ryvu Therapeutics SA
―
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
―
Captor Therapeutics SA
―